MindMaze Therapeutics Holding SA

Pharmaceutical company · Ch-1202 Geneva, Geneva, Switzerland · OTC: MMTZF

MindMaze Therapeutics Holding SA is a pharmaceutical company headquartered in Ch-1202 Geneva, Geneva, Switzerland. Its shares trade on OTC under the ticker MMTZF. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

MindMaze Therapeutics Holding at a glance

Typepharmaceutical company

HeadquartersCh-1202 Geneva, Geneva, Switzerland

Stock listingOTC: MMTZF

SEC industryPharmaceutical Preparations

SEC CIK1854078

What does MindMaze Therapeutics Holding do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $16.4 million sold (2021).

Frequently asked questions about MindMaze Therapeutics Holding

Where is MindMaze Therapeutics Holding headquartered?

MindMaze Therapeutics Holding SA is headquartered in Ch-1202 Geneva, Geneva, Switzerland.

What does MindMaze Therapeutics Holding do?

MindMaze Therapeutics Holding SA is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is MindMaze Therapeutics Holding a public company?

Yes. MindMaze Therapeutics Holding SA trades on OTC under the ticker MMTZF.

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.